Breast Cancer Rehabilitation Needs and Service Uptake

NCT06753357 | Not Yet Recruiting

• 1 other identifier: RIG202403-006PR
• Study Type: observational
• Target: 376
• Locations: 1 country
• Sites: 1

Brief Summary

The investigators are attempting to verify the prevalence of cancer rehabilitation needs at our institution in breast cancer patients. The investigators also want to assess 1) self-perceived needs for cancer rehabilitation services, 2) awareness, willingness, and patient health beliefs as determinants for cancer rehabilitation-seeking behaviour, and 3) the modifiable patient factors driving the mismatch between needs and uptake in our population. Patients attending outpatient clinics in our hospital will be approached to answer a questionnaire designed to find out this information. The investigators hope that the results will ultimately inform the design of better triage and referral systems that match patients to services based on their rehabilitation needs. The investigators believe that local survivors of breast cancer have unmet rehabilitation needs and that it is possible to evaluate their readiness to seek access to rehabilitation services as well as identify mismatches between provided and desired services through the administration of a cancer rehabilitation questionnaire (CRQ).

Conditions

Breast Cancer; Cancer Survivorship; Health Attitude

Keywords

Breast cancer; Cancer rehabilitation; Rehabilitation needs; Rehabilitation service uptake; Cancer survivorship; Health Belief Model; Technological enablers

Outcome Measures

Primary Outcomes (1)

• Symptom/impairment prevalence

  The prevalence of reported symptoms and impairments among breast cancer survivors.

  At the point of recruitment

Secondary Outcomes (4)

• Awareness of available support

  At the point of recruitment

• Willingness to receive support

  At the point of recruitment

• Health beliefs in relation to receiving rehabilitation support

  At the point of recruitment

• Agreement on level of care

  At the point of recruitment

Study Arms (1)

Eligible patients

Female patients from the Breast Surgery clinic at Changi General Hospital (with referrals from the on-site Medical Oncology clinic). A consecutive purposive sample of 400 participants will be recruited. There are no race-based or minority-based subject restrictions. Male patients with breast cancer are rare and are thus excluded from recruitment. Patients will be approached by a clinical research co-ordinator (CRC) or study team member who will explain the study and seek consent for recruitment.

Eligibility Criteria

• Age: 21 Years+
• Sex: female
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Consecutive purposive sample of all female patients with breast cancer in the Breast Surgery and Medical Oncology clinics.

You may qualify if:

• Female patients
• Age 21yrs old and above
• Histological diagnosis of breast cancer at any stage (or clinical consensus at a Tumour Board meeting, for example if the condition is metastatic and biopsy is not indicated for any reason)
• Started treatment (surgical, medical, radiotherapeutic, or otherwise) with curative or palliative intent
• Speak English, Mandarin, or Malay, or Tamil, and are able to understand a verbally-translated version of the questionnaire
• Able to provide informed consent

You may not qualify if:

• Unable to answer the questionnaire for any reasons such as cognitive impairment or sensory dysfunction
• Declined participation

Sponsors & Collaborators

• Changi General Hospital: lead

Study Sites (1)

Changi General Hospital

Singapore, Singapore, 554341, Singapore

Location

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Breast Diseases; Skin Diseases; Skin and Connective Tissue Diseases

Study Officials

• Edmund JR Neo, MBBS MRCP

  Singapore Health Services Pte Ltd

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Edmund JR Neo, MBBS MRCP

CONTACT

065 6936 6462; edmund.neo.jin.rui@singhealth.com.sg

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: December 17, 2024
• First Posted: December 31, 2024
• Study Start: January 1, 2025
• Primary Completion: December 1, 2025
• Study Completion: December 1, 2025
• Last Updated: December 31, 2024

Record last verified: 2024-12

Data Sharing

• IPD Sharing: Will not share

Locations

SG (1)